Novonix (NVX) Payables (2020 - 2025)

Novonix's Payables history spans 6 years, with the latest figure at $75.4 million for Q4 2025.

  • For Q4 2025, Payables rose 87.57% year-over-year to $75.4 million; the TTM value through Dec 2025 reached $75.4 million, up 87.57%, while the annual FY2025 figure was $75.4 million, 87.57% up from the prior year.
  • Payables reached $75.4 million in Q4 2025 per NVX's latest filing, up from $40.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $75.4 million in Q4 2025 to a low of $3.6 million in Q2 2021.
  • Average Payables over 5 years is $22.8 million, with a median of $6.8 million recorded in 2022.
  • Peak YoY movement for Payables: decreased 4.72% in 2023, then soared 506.56% in 2024.
  • A 5-year view of Payables shows it stood at $3.6 million in 2021, then soared by 94.9% to $7.0 million in 2022, then fell by 4.72% to $6.6 million in 2023, then skyrocketed by 506.56% to $40.2 million in 2024, then surged by 87.57% to $75.4 million in 2025.
  • Per Business Quant, the three most recent readings for NVX's Payables are $75.4 million (Q4 2025), $40.2 million (Q4 2024), and $6.6 million (Q4 2023).